Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
De Falco F, Del Papa B, Baldoni S, Sabatini R, Falzetti F, Di Ianni M, Martelli MP, Mezzasoma F, Pelullo M, Marconi P, Sportoletti P, Screpanti I, Rosati E. De Falco F, et al. Among authors: falzetti f. Cell Death Dis. 2018 Nov 26;9(12):1160. doi: 10.1038/s41419-018-1185-6. Cell Death Dis. 2018. PMID: 30478302 Free PMC article.
Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum.
Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, Iacucci R, Zei T, Martelli MP, Gambelunghe C, et al. Aversa F, et al. Among authors: falzetti f. Blood. 1994 Dec 1;84(11):3948-55. Blood. 1994. PMID: 7524753 Free article. Clinical Trial.
Mesenchymal cells: a vehicle for gene therapy.
Di Ianni M, Del Papa B, De Ioanni M, Sportoletti P, Moretti L, Falzetti F, Martelli MF, Tabilio A. Di Ianni M, et al. Among authors: falzetti f. Blood Cells Mol Dis. 2004 Nov-Dec;33(3):267-70. doi: 10.1016/j.bcmd.2004.08.014. Blood Cells Mol Dis. 2004. PMID: 15528142
Graft engineering for allogeneic haploidentical stem cell transplantation.
Tabilio A, Falzetti F, Zei T, De Ioanni M, Bonifacio E, Battelli F, Iacucci Ostini R, Ballanti S, Cimminiello M, Capponi M, Silvani C, Minelli O, Fettucciari K, Marconi P, Rosati E, Santucci A, Di Ianni M, Aversa F, Martelli MF. Tabilio A, et al. Among authors: falzetti f. Blood Cells Mol Dis. 2004 Nov-Dec;33(3):274-80. doi: 10.1016/j.bcmd.2004.08.016. Blood Cells Mol Dis. 2004. PMID: 15528144 Review.
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, Felicini R, Falcinelli F, Velardi A, Ruggeri L, Aloisi T, Saab JP, Santucci A, Perruccio K, Martelli MP, Mecucci C, Reisner Y, Martelli MF. Aversa F, et al. Among authors: falzetti f. J Clin Oncol. 2005 May 20;23(15):3447-54. doi: 10.1200/JCO.2005.09.117. Epub 2005 Mar 7. J Clin Oncol. 2005. PMID: 15753458 Clinical Trial.
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population.
Sportoletti P, Del Papa B, De Ioanni M, Moretti L, Bonifacio E, Lanterna V, Bell A, Fettucciari K, Carnevali E, Zei T, Falzetti F, Martelli MF, Tabilio A, Di Ianni M. Sportoletti P, et al. Among authors: falzetti f. Biol Blood Marrow Transplant. 2006 Dec;12(12):1250-60. doi: 10.1016/j.bbmt.2006.09.001. Biol Blood Marrow Transplant. 2006. PMID: 17162206 Free article.
109 results